Igitekerezo cy'ikibyimba
Tumor ni ibinyabuzima bishya biterwa no gukwirakwira bidasanzwe kwingirabuzimafatizo mu mubiri, bikunze kugaragara nkimitsi idasanzwe (lump) mubice byumubiri. Kubyimba ni ibisubizo byihungabana rikomeye ryimikorere yo gukura kwingirabuzimafatizo hifashishijwe ibintu bitandukanye bya tumorigenic. Ikwirakwizwa ridasanzwe ry'uturemangingo tuganisha ku kubyimba byitwa neoplastique prolifration.
Muri 2019, Akagari ka Kanseri kasohoye inkuru vuba aha. Abashakashatsi basanze metformine ishobora kubuza cyane gukura kw'ibibyimba mu kwiyiriza ubusa, banasaba ko inzira ya PP2A-GSK3β-MCL-1 ishobora kuba intego nshya yo kuvura ibibyimba.
Itandukaniro nyamukuru hagati yikibyimba cyiza na kanseri mbi
Ikibyimba cyiza: gukura gahoro, capsule, kubyimba gukura, kunyerera gukoraho, imbibi zisobanutse, nta metastasis, muri rusange guhanura neza, ibimenyetso byo kwikuramo byaho, muri rusange nta mubiri wose, mubisanzwe ntabwo bitera urupfu rwabarwayi.
Ikibyimba kibi (kanseri): gukura byihuse, gukura gutera, kwizirika ku ngingo ziyikikije, kutabasha kwimuka iyo byakozweho, imipaka idasobanutse, metastasis yoroshye, kwisubiramo byoroshye nyuma yo kuvurwa, umuriro muke, ubushake buke mu cyiciro cya mbere, gutakaza ibiro, kunanirwa cyane, kubura amaraso ndetse no kugira umuriro mugihe cyanyuma, nibindi.
"Kubera ko ibibyimba byiza n'ibibyimba bibi bitagaragara gusa ku mavuriro atandukanye, ariko icy'ingenzi ni uko ibyo bavuga bitandukana, bityo rero iyo ubonye ikibyimba mu mubiri wawe n'ibimenyetso byavuzwe haruguru, ugomba gushaka inama z'ubuvuzi mu gihe gikwiye."
Kuvura umuntu ku giti cye
Umushinga wa Genome yumuntu numushinga mpuzamahanga wa kanseri
Umushinga wa Human Genome, watangijwe ku mugaragaro muri Amerika mu 1990, ugamije gufungura kodegisi zose zigera ku 100.000 mu mubiri w'umuntu no gushushanya ingirabuzimafatizo z'umuntu.
Mu 2006, umushinga mpuzamahanga wa kanseri ya kanseri, watangijwe n’ibihugu byinshi, ni ubundi bushakashatsi bukomeye bwa siyansi nyuma y’umushinga wa muntu.
Ibibazo nyamukuru mukuvura ibibyimba
Kwisuzumisha no kuvura kugiti cyawe = Kwipimisha kugiti cyawe + imiti igamije
Ku barwayi benshi batandukanye barwaye indwara imwe, uburyo bwo kuvura ni ugukoresha imiti imwe na dosiye isanzwe, ariko mubyukuri, abarwayi batandukanye bafite itandukaniro rikomeye mubikorwa byo kuvura no kubyitwaramo nabi, kandi rimwe na rimwe iri tandukaniro riranica.
Ubuvuzi bugamije gufata imiti bufite ibimenyetso biranga kwica cyane uturemangingo twibibyimba tutiriwe twica cyangwa gake byangiza ingirabuzimafatizo zisanzwe, bifite ingaruka nkeya ugereranije, zizamura neza ubuzima bwiza ningaruka zo kuvura abarwayi.
Kuberako ubuvuzi bugenewe kugenewe kwibasira molekile yihariye, birakenewe kumenya genes yibibyimba no kumenya niba abarwayi bafite intego bahuye mbere yo gufata ibiyobyabwenge, kugirango bigire ingaruka nziza.
Tumor gene detection
Tumor gene detection nuburyo bwo gusesengura no gukurikirana ADN / RNA ya selile yibibyimba.
Akamaro ko gutahura ibibyimba ni ukuyobora guhitamo imiti ivura imiti (imiti igamije, imiti igabanya ubukana hamwe na sida nshya, kuvura bitinze), no guhanura ibizongera kubaho.
Ibisubizo byatanzwe na Acer Macro & Micro-Ikizamini
Umuntu EGFR Gene 29 Igikoresho cyo Guhindura Ibihinduka (Fluorescence PCR)
Ikoreshwa mugutahura neza ihinduka ryimiterere ihindagurika muri exon 18-21 ya EGFR gene kubantu barwayi ba kanseri yibihaha itari mito mito muri vitro.
1. Kwinjiza kugenzura imiterere yimbere yimbere muri sisitemu irashobora gukurikirana byimazeyo inzira yubushakashatsi no kwemeza ubuziranenge bwubushakashatsi.
.
3.
KRAS 8 Igikoresho cyo Gutahura (Fluorescence PCR)
Ubwoko umunani bwimiterere ihindagurika muri codon ya 12 na 13 za K-ras zikoreshwa mugushakisha neza ADN yakuwe mubice bya paraffine byashyizwemo na virusi muri vitro.
1. Kwinjiza kugenzura imiterere yimbere yimbere muri sisitemu irashobora gukurikirana byimazeyo inzira yubushakashatsi no kwemeza ubuziranenge bwubushakashatsi.
.
3.
Umuntu ROS1 Fusion Gene Mutation Detection Kit (Fluorescence PCR)
Ikoreshwa mukumenya neza ubwoko 14 bwimiterere ya mutation ya ROS1 fusion mubantu barwaye kanseri yibihaha itari mito mito muri vitro.
1. Kwinjiza kugenzura imiterere yimbere yimbere muri sisitemu irashobora gukurikirana byimazeyo inzira yubushakashatsi no kwemeza ubuziranenge bwubushakashatsi.
2. Gukenera cyane: kopi 20 za mutation ya fusion.
3.
Umuntu EML4-ALK Fusion Gene Mutation Detection Kit (Fluorescence PCR)
Byakoreshejwe kugirango hamenyekane neza ubwoko 12 bwimiterere ya EML4-ALK fusion gene kubantu barwayi ba kanseri yibihaha itari mito mito muri vitro.
1. Kwinjiza kugenzura imiterere yimbere yimbere muri sisitemu irashobora gukurikirana byimazeyo inzira yubushakashatsi no kwemeza ubuziranenge bwubushakashatsi.
2. Gukenera cyane: kopi 20 za mutation ya fusion.
3.
Umuntu BRAF Gene V600E Igikoresho cyo Guhindura Mutation (Fluorescence PCR)
Ikoreshwa mukumenya neza ihinduka rya mutation ya BRAF gene V600E muri paraffin yashyizwemo ingirabuzimafatizo za melanoma ya muntu, kanseri yibara, kanseri ya tiroyide na kanseri y'ibihaha muri vitro.
1. Kwinjiza kugenzura imiterere yimbere yimbere muri sisitemu irashobora gukurikirana byimazeyo inzira yubushakashatsi no kwemeza ubuziranenge bwubushakashatsi.
.
3.
Ingingo Oya | Izina ryibicuruzwa | Ibisobanuro |
HWTS-TM006 | Umuntu EML4-ALK Fusion Gene Mutation Detection Kit (Fluorescence PCR) | Ibizamini 20 / kit Ibizamini 50 / kit |
HWTS-TM007 | Umuntu BRAF Gene V600E Igikoresho cyo Guhindura Mutation (Fluorescence PCR) | Ibizamini 24 Ibizamini 48 |
HWTS-TM009 | Umuntu ROS1 Fusion Gene Mutation Detection Kit (Fluorescence PCR) | Ibizamini 20 / kit Ibizamini 50 / kit |
HWTS-TM012 | Umuntu EGFR Gene 29 Igikoresho cyo Guhindura Ibihinduka (Fluorescence PCR) | Ibizamini 16 32 ibizamini / kit |
HWTS-TM014 | KRAS 8 Igikoresho cyo Gutahura (Fluorescence PCR) | Ibizamini 24 Ibizamini 48 |
HWTS-TM016 | Umuntu TEL-AML1 Fusion Gene Mutation Detection Kit (Fluorescence PCR) | Ibizamini 24 |
HWTS-GE010 | Umuntu BCR-ABL Fusion Gene Mutation Detection Kit (Fluorescence PCR) | Ibizamini 24 |
Igihe cyo kohereza: Apr-17-2024